Schedule 13G ownership disclosure

APPLIED THERAPEUTICS INC

Common Stock, par value $0.0001 per share · CUSIP: 03828A101

Event date: 2025-03-31

Filing-level shares
4,676,097.00
Percent of class
3.30%
  • Schonfeld Strategic Advisors LLC

    Shares: 4,676,097.00 · Class: 3.30%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193805-25-000666
Form type
SCHEDULE 13G/A
Filer
Applied Therapeutics, Inc.
CIK
CIK 1697532
Filed
May 15, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub